Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2026-05-08 09:23 am Purchase | 2026-05-04 | 13G | REIN THERAPEUTICS INC RNTX | Lynwood Capital Management Inc. | 4,750,000 6.100% | 4,750,000 (New Position) | Filing History |
| 2026-01-23 4:00 pm Purchase | 2026-01-15 | 13G | KAZIA THERAPEUTICS LTD SPONSOR KZIA | Lynwood Capital Management Inc. | 307,998,500 5.400% | 307,998,500 (New Position) | Filing History |
| 2023-02-14 4:35 pm Purchase | 2022-12-31 | 13G | BRIACELL THERAPEUTICS INC BCTX | Lynwood Capital Management Inc. | 9,733 9.300% | 3,933 (+67.81%) | Filing History |
| 2022-08-01 07:00 am Purchase | 2022-07-20 | 13G | BRIACELL THERAPEUTICS INC BCTX | Lynwood Capital Management Inc. | 5,800 5.600% | 567 (+10.84%) | Filing History |
| 2022-02-11 08:00 am Sale | 2021-12-31 | 13G | BRIACELL THERAPEUTICS INC BCTX | Lynwood Capital Management Inc. | 5,233 4.920% | -634 (-10.81%) | Filing History |
| 2021-08-17 4:04 pm Purchase | 2021-08-09 | 13G | BRIACELL THERAPEUTICS INC BCTX | Lynwood Capital Management Inc. | 5,867 5.800% | 5,867 (New Position) | Filing History |